EMEA-000733-PIP02-12
Key facts
Invented name |
|
Active substance |
strontium succinate
|
Therapeutic area |
Immunology-Rheumatology-Transplantation
|
Decision number |
P/0022/2013
|
PIP number |
EMEA-000733-PIP02-12
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of osteoporosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Les Laboratoires Servier
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|